These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3557308)

  • 1. Anticalmodulin autoantibody in liver diseases: a new antibody against a cytoskeleton-related protein.
    Ikeda Y; Toda G; Hashimoto N; Aotsuka S; Yokohari R; Maruyama T; Oka H
    Hepatology; 1987; 7(2):285-93. PubMed ID: 3557308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of antibodies against calmodulin in patients with various liver diseases].
    Tsuruya T; Hata K; Kamimura T; Hayakawa A; Aoyagi Y; Asakura H; Ishihara K; Toshima M; Soga K; Sibasaki K
    Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):131-7. PubMed ID: 2030558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dot-immunobinding assay for antimitochondrial antibodies.
    Penner E; Goldenberg H; Meryn S; Gordon J
    Hepatology; 1986; 6(3):381-4. PubMed ID: 3519415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common lupus anti-DNA antibody idiotypes in chronic liver diseases.
    Konikoff F; Isenberg DA; Kooperman O; Kennedy RC; Rauch J; Theodor E; Shoenfeld Y
    Clin Immunol Immunopathol; 1987 May; 43(2):265-72. PubMed ID: 3568459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of autoantibody against calmodulin in acute hepatitis and chronic liver diseases].
    Ikeda Y
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2092. PubMed ID: 3795581
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA.
    Leibovitch L; George J; Levi Y; Bakimer R; Shoenfeld Y
    Immunol Lett; 1995 Dec; 48(2):129-32. PubMed ID: 8719111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory tests for diagnosis of autoimmune diseases.
    Nakamura RM; Chisari FV; Edgington TS
    Prog Clin Pathol; 1975; 6():177-203. PubMed ID: 1105671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-pyruvate dehydrogenase complex antibody in primary biliary cirrhosis by an enzyme-linked immunosorbent assay.
    Tsuruya T
    Gastroenterol Jpn; 1990 Aug; 25(4):471-7. PubMed ID: 2210221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear autoantibodies in chronic liver diseases.
    Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
    Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.
    Doniach D; Roitt IM; Walker JG; Sherlock S
    Clin Exp Immunol; 1966 Jul; 1(3):237-62. PubMed ID: 5330183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies and serum immunoglobulins in chronic liver diseases.
    Ladefoged K; Andersen P; Jørgensen J
    Acta Med Scand; 1979; 205(1-2):103-9. PubMed ID: 310633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
    Gruber R; Felber E; Pape GR; Höchtlen-Vollmar W; Riethmüller G
    J Clin Lab Anal; 1994; 8(5):284-92. PubMed ID: 7807283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.
    Mutimer DJ; Fussey SP; Yeaman SJ; Kelly PJ; James OF; Bassendine MF
    Hepatology; 1989 Oct; 10(4):403-7. PubMed ID: 2673968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulins and organ non-specific antibodies in diseases of the liver.
    Husby G; Skrede S; Blomhoff JP; Jacobsen CD; Berg K; Gjone E
    Scand J Gastroenterol; 1977; 12(3):297-304. PubMed ID: 866991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded DNA-binding capacity of serum in acute and chronic liver disease.
    Jain S; Markham R; Thomas HC; Sherlock S
    Clin Exp Immunol; 1976 Oct; 26(1):35-41. PubMed ID: 1087214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?
    Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME
    Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
    Imai H; Nakano Y; Kiyosawa K; Tan EM
    Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide.
    Toda G; Ikeda Y; Kashiwagi M; Iwamori M; Oka H
    Hepatology; 1990 Oct; 12(4 Pt 1):664-70. PubMed ID: 2210670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.